Katie Rose Ryan

Katie Rose Ryan

Auto-generated profile, based on publicly available information

Katie Rose Ryan

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DSDebasmita Saha
Debasmita Saha
KRKatie Rose Ryan
Katie Rose Ryan
NLNaga Rajiv Lakkaniga
Naga Rajiv Lakkaniga
BABaku Acharya
Baku Acharya
NGNoemi Garcia Garcia
Noemi Garcia Garcia
BFBrendan Frett
Brendan Frett

30 September 2020 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
KRKatie R. Ryan
Katie R. Ryan
FGFrancis Giles
Francis Giles
GMGareth J. Morgan
Gareth J. Morgan

21 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CEClara L Essmann
Clara L Essmann
KRKatie R Ryan
Katie R Ryan
MEMuna Elmi
Muna Elmi
KBKimberley Bryon-Dodd
Kimberley Bryon-Dodd
APAndrew Porter
Andrew Porter
SNStephen Nurrish
Stephen Nurrish
The small GTPase RhoA plays a crucial role in the regulation of neuronal signalling to generate behaviour. In the developing nervous system RhoA is known to regulate the actin cytoskeleton, however the effectors of RhoA-signalling in adult neurons remain largely unidentified. We have previously shown that activation of the RhoA ortholog (RHO-1) in C. elegans cholinergic motor neurons triggers hyperactivity of these neurons and loopy locomotion with exaggerated body bends. This is achieved in part through increased diacylglycerol (DAG) levels and the recruitment of the synaptic vesicle protein UNC-13 to synaptic release sites, however other pathways remain to be identified. Dopamine, which is negatively regulated by the dopamine re-uptake transporter (DAT), has a central role in modulating locomotion in both humans and C. elegans. In this study we identify a new pathway in which RHO-1 regulates locomotory behaviour by repressing dopamine signalling, via DAT-1, linking these two pathways together. We observed an upregulation of dat-1 expression when RHO-1 is activated and show that loss of DAT-1 inhibits the loopy locomotion phenotype caused by RHO-1 activation. Reducing dopamine signalling in dat-1 mutants through mutations in genes involved in dopamine synthesis or in the dopamine receptor DOP-1 restores the ability of RHO-1 to trigger loopy locomotion in dat-1 mutants. Taken together, we show that negative regulation of dopamine signalling via DAT-1 is necessary for the neuronal RHO-1 pathway to regulate locomotion.

8 February 2021 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
DSDebasmita Saha
Debasmita Saha
KRKatie Rose Ryan
Katie Rose Ryan
NLNaga Rajiv Lakkaniga
Naga Rajiv Lakkaniga
ESErica Lane Smith
Erica Lane Smith
BFBrendan Frett
Brendan Frett

9 May 2024 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
BABaku Acharya
Baku Acharya
DSDebasmita Saha
Debasmita Saha
NGNoemi Garcia Garcia
Noemi Garcia Garcia
DADaniel Armstrong
Daniel Armstrong
BJBaha'A Jabali
Baha'A Jabali
KRKatie Rose Ryan
Katie Rose Ryan

24 February 2026 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
NGNoemi Garcia Garcia
Noemi Garcia Garcia
TNThanh Ha Vy Nguyen
Thanh Ha Vy Nguyen
DRDane Richey
Dane Richey
ECEmily F Cox
Emily F Cox
JJJon Coca Juaristi
Jon Coca Juaristi
KRKatie R Ryan
Katie R Ryan
Rnd3 regulates cellular processes commonly dysregulated in cancer, and altered Rnd3 expression has been linked to several cancer types. Here, we show lung adenocarcinoma patients expressing low levels of Rnd3 have significantly higher survival rates. To gain mechanistic insight into this correlation, we knocked down Rnd3 in lung adenocarcinoma A549 and H460 cell lines and patient-derived lung-to-brain metastasis (PDLBM) cell lines as a proxy for advanced disease. Depletion of Rnd3 expression decreases cell invasion and migration, two hallmarks of metastasis, independently of RhoA-ROCK1 signaling in both lung adenocarcinoma and PDLBM cell lines, indicating the involvement of a novel pathway. The expression of alpha 5 integrin was increased in Rnd3-depleted A549 cells, and knocking down alpha 5 integrin restored cell migration and invasion rates in A549 cells. Identification of a RhoA-ROCK1-independent mechanism by which Rnd3 modulates alpha 5 integrin expression to control cell migration and invasion provides new insights into the molecular basis of pro-malignant properties. These properties that drive the metastatic potential of lung adenocarcinoma may be exploited to target metastatic disease.